Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | CNR2 | P34972 | 4/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PPM1B | O75688 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.39 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.39 |
| ▸ | PPP5C | P53041 | 1/20 | 0.39 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3495647 | 0.93 | CNR2 (0.53) | SMN1; SMN2CNR2CNR1ALDH1A1CYP19A1 | |
| SCHEMBL3496388 | 0.93 | CNR2 (0.53) | SMN1; SMN2CNR2CNR1ALDH1A1CYP19A1 | |
| SCHEMBL13311367 | 0.89 | L3MBTL1 (0.42) | SMN1; SMN2CNR2CNR1ALDH1A1L3MBTL1 | |
| SCHEMBL3495026 | 0.89 | L3MBTL1 (0.42) | SMN1; SMN2CNR2CNR1ALDH1A1L3MBTL1 | |
| SCHEMBL13311489 | 0.89 | ALDH1A1 (0.46) | SMN1; SMN2CNR2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL17532421 | 0.89 | ALDH1A1 (0.46) | SMN1; SMN2CNR2ALDH1A1L3MBTL1RAB9A | |
| SCHEMBL17532425 | 0.87 | RAB9A (0.52) | SMN1; SMN2CNR2CNR1ALDH1A1L3MBTL1 | |
| SCHEMBL17532429 | 0.85 | PPM1B (0.48) | SMN1; SMN2ALDH1A1L3MBTL1RAB9AMEN1 | |
| SCHEMBL14344341 | 0.81 | PPM1B (0.45) | SMN1; SMN2ALDH1A1L3MBTL1RAB9APPM1B | |
| SCHEMBL25474242 | 0.81 | CNR2 (0.39) | SMN1; SMN2CNR2CNR1L3MBTL1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100137294-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | GENETIC TECHNOLOGIES LIMITED (AU) | 2010-06-03 | — | — | US | claimed |
| EP-2086534-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | Genetic Technologies Limited (AU) | 2009-08-12 | — | — | EP | claimed |
| WO-2008058342-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | GENETIC TECHNOLOGIES LIMITED (AU) | 2008-05-22 | — | — | WO | claimed |
| US-8455410-B2 | Lubricating oil composition | INFINEUM INTERNATIONAL LIMITED (GB) | 2013-06-04 | — | — | US | disclosed |
| US-8455410-B2 | Lubricating oil composition | INFINEUM INTERNATIONAL LIMITED (GB) | 2013-06-04 | — | — | US | disclosed |
| EP-2453000-A1 | Lubricating Oil Composition comprising a hydrogenated imide derived from a Diels-Alder adduct of maleic anhydride and a furan | Infineum International Limited (GB) | 2012-05-16 | — | — | EP | disclosed |
| US-20120111299-A1 | LUBRICATING OIL COMPOSITION | INFINEUM INTERNATIONAL LIMITED (GB) | 2012-05-10 | — | — | US | disclosed |
| US-20120111299-A1 | LUBRICATING OIL COMPOSITION | INFINEUM INTERNATIONAL LIMITED (GB) | 2012-05-10 | — | — | US | disclosed |
| US-20100137294-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | GENETIC TECHNOLOGIES LIMITED (AU) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137294-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | PPP1R10, TASP1, PPP5C | SMN1; SMN2 3065/4885CNR2 4377/4885CNR1 3767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.